SEC Form 8-K Summary
Registrant: Brilliant Acquisition Corporation, not T3 Defense Inc. The filing reports events dated May 22, 2023, with a related press release dated May 23, 2023.
Business Context and Reporting Period
Brilliant is a special purpose acquisition company pursuing a proposed business combination with Nukkleus, Inc. Under the merger agreement, a merger subsidiary would merge into Brilliant, which would become a wholly owned subsidiary of Nukkleus. This Form 8-K was filed under Items 1.01, 2.03, 7.01 and 9.01.
Key Financial and Capital Structure Information
| Item | Reported information |
|---|---|
| New obligation | Unsecured, non-interest-bearing promissory note issued to Nukkleus for aggregate principal of $32,450. |
| Maturity | The note matures upon closing of Brilliant’s initial business combination. |
| Repayment if transaction fails | Repayment would be made only from amounts remaining outside Brilliant’s trust account, if any. |
| Use of proceeds | Proceeds were deposited into Brilliant’s trust account in connection with extending the business-combination deadline. |
| Revenue, profit and cash flow | The filing does not provide current-period revenue, earnings, cash-flow, margin or operating-performance metrics. |
| Debt and liquidity | The filing identifies the $32,450 promissory note but does not provide a broader debt, cash balance, trust-account balance or liquidity analysis. |
Material Changes Versus the Prior Comparable Period
- Brilliant incurred a new $32,450 unsecured obligation to Nukkleus.
- The period for completing the initial business combination was extended by one month, from the prior deadline to June 23, 2023.
- The filing does not provide a comparable-period income statement, balance sheet or cash-flow analysis.
Guidance, Outlook, Risks and Unusual Items
Management did not provide financial guidance. The principal near-term objective remains completion of the proposed Nukkleus transaction by June 23, 2023.
- The transaction may not close on time or at all.
- Completion depends on conditions including shareholder approvals, satisfaction of the minimum trust-account amount after redemptions and required governmental or regulatory approvals.
- Failure to complete a business combination could result in repayment of the note only from funds outside the trust account, if any.
- Risks include potential Nasdaq listing issues, transaction-related litigation, redemption levels, volatility in the securities, changes in regulation and the ability to execute post-combination business plans.
- The proposed transaction remains subject to SEC filings and review, including the Form S-4 registration statement and related proxy statement/prospectus.
Important Facts for Investors to Verify
- Whether the proposed Nukkleus-Brilliant business combination received all required approvals and closed by the June 23, 2023 deadline.
- The final trust-account balance, shareholder redemptions and minimum cash condition.
- The terms and repayment status of the $32,450 promissory note.
- The definitive proxy statement/prospectus, amendments to the Form S-4 and any subsequent SEC filings describing transaction terms and risks.
- Any changes to Brilliant’s Nasdaq listing status and the status of its ordinary shares, rights and warrants.